This variant typically occurs in late infancy, presents a more mature CD10-positive B-cell precursor phenotype, shares similar cytogenetic abnormalities with ALL in older children, and is associated with better outcomes [18,19]. This evidence concerns the gene MME and acute lymphoblastic leukemia.